| Literature DB >> 30054793 |
K M A Dreuning1, C E M Ten Broeke2, J W R Twisk3, S G F Robben4, R R van Rijn5, J I M L Verbeke6, L W E van Heurn2, J P M Derikx2.
Abstract
OBJECTIVES: The incidence of children developing metachronous contralateral inguinal hernia (MCIH) is 7-15%. Contralateral groin exploration during unilateral hernia repair can prevent MCIH development and subsequent second surgery and anaesthesia. Preoperative ultrasonography is a less invasive strategy and potentially able to detect contralateral patent processus vaginalis (CPPV) prior to MCIH development.Entities:
Keywords: Child; Hernia, inguinal; Ultrasonography
Mesh:
Year: 2018 PMID: 30054793 PMCID: PMC6302883 DOI: 10.1007/s00330-018-5625-6
Source DB: PubMed Journal: Eur Radiol ISSN: 0938-7994 Impact factor: 5.315
Fig. 1PRISMA flow chart of the study selection
Study characteristics and patient demographics of the included studies (n = 14)
| Author | Year | Country | Study design | Index test | Reference test | Patients | Male | Female | Age (mean/median) | Follow-up (months) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Positive ITR | Negative ITR | ||||||||||
| Chen | 1998 | Taiwan | Cohort study | Ultrasound | Surgical exploration | None | 203 | 203 (100) | – | 3 days–13 years (mean 32.6 months) | – |
| Chou | 1996 | Taiwan | Cohort study | Ultrasound | Surgical exploration | Surgical exploration | 179 | Unclear | Unclear | 3 days–14 years (mean 43.1 months) | – |
| Erez | 1996 | Israel | Cohort study | Ultrasound | Surgical exploration | Clinical follow-up | 200 | Unclear | Unclear | 6 months–13 years | 36–48 |
| Hasanuzzaman | 2011 | Bangladesh | Cohort study | Ultrasound | Surgical exploration | None | 30 | 17 (56.7) | 13 (43.3) | 2.5–14 years | – |
| Hata | 2004 | Japan | Cohort study | Ultrasound | Surgical exploration | None | 348 | 168 (48.3) | 180 (51.7) | Unclear | – |
| Kaneda | 2015 | Japan | Cohort study | Ultrasound | Clinical follow-up | Clinical follow-up | 105 | 47 (44.8) | 58 (55.2) | 5 days–13 years (median 47 months) | 36 |
| Kazez | 1998 | Turkey | Cohort study | Ultrasound | Surgical exploration | Surgical exploration | 46 | 41 (89.1) | 5 (10.9) | 35 days–2 years (mean 11 months) | – |
| Kazez | 2001 | Turkey | Cohort study | Ultrasound | Clinical follow-up | Clinical follow-up | 29 | 29 (100) | – | 50 days–4 years (mean 20.4 months) | 11 |
| Kervancioglu | 2000 | Turkey | Cohort study | Ultrasound | Surgical exploration | Clinical follow-up | 121 | Unclear | Unclear | 36 day–15 years (mean 4.7 years) | 6–12 |
| Lawrenz | 1994 | Scotland | Cohort study | Ultrasound | Surgical exploration | Surgical Exploration | 23 | 23 (100) | – | 0–325 days (mean 86 days) | – |
| Shehata | 2013 | Saudi Arabia | Cohort study | Ultrasound | Surgical exploration | Surgical Exploration | 246 | 207 (84.1) | 39 (15.9) | 0–1 year (median 45 weeks) | – |
| Toki | 2003 | Japan | Cohort study | Ultrasound | Surgical exploration | Clinical follow-up | 271 | 163 (60.1) | 108 (39.9) | 0–14 years (median 2 years) | 24 |
| Uno | 1992 | Japan | Case-control study | Ultrasound | Surgical exploration | Clinical follow-up | 32 | 21 (65.6) | 11 (34.4) | < 15 years | ≥ 12 |
| Zaidi | 2017 | Pakistan | Cross-sectional study | Ultrasound | Surgical exploration | Clinical follow-up | 287 | 264 (92.0) | 23 (8.0) | 0.5–132 months | ≤ 24 |
ITR index test results
Index test characteristics and diagnostic test criteria of the included studies (n = 14)
| Author, year | Index test | Transducer | Examination | Diagnostic criteria for contralateral PPV or inguinal hernia | WLIRa of contralateral hernia |
|---|---|---|---|---|---|
| Chen, 1998 | Ultrasound | 7.0 MHz linear array transducer | At rest and straining | (A) Presence of bowel loops or omentum in inguinal canal | PPV > 4 mm |
| Chou, 1996 | Ultrasound | 7.0 MHz linear array transducer | At rest and straining | (A) Diameter of internal inguinal ring > 4 mm | PPV > 4 mm |
| Erez, 1996 | Ultrasound | 7.0 MHz linear array transducer | At rest, no straining | The presence of fluid, characterised by a homogeneous and more hypoechoic appearance, wider than a PPV | PPV > 3 mm (< 1 year) |
| Hasanuzzaman, 2011 | Ultrasound | 7.5 MHz linear array transducer | At rest and straining | CPPV that was not detectable at rest could be visualised as a hydrocele owing to the inflow or peritoneal fluid into a processus vaginalis on straining | Unclear |
| Hata, 2004 | Ultrasound | 7.5 MHz linear array transducer | At rest and straining | (A) Hydrocele, owing to inflow of physiologic ascites into the processus vaginalis, detectable while straining | Unclear |
| Kaneda, 2015 | Ultrasound | 10.0 MHz linear array transducer | At rest, no straining | Major axis of the contralateral PPV in millimetres | Unclear |
| Kazez, 1998 | Ultrasound | 5.0 MHz linear array transducer | Unclear | (A) PPV: 2–3 mm | PPV > 4 mm |
| Kazez, 2001 | Ultrasound | 7.5 MHz linear array transducer | Unclear | (A) PPV: 2–4 mm | PPV > 4 mm |
| Kervancioglu, 2000 | Ultrasound | 7.5 MHz linear array transducer | At rest, no straining | (A) Presence of fluid, bowel loops or omentum in the inguinal canal | PPV > 4 mm |
| Lawrenz, 1994 | Ultrasound | 7.0 MHz linear array transducer | At rest and straining | (A) PPV | Unclear |
| Shehata, 2013 | Ultrasound | 10.0 MHz linear array transducer | At rest and straining | (A) PPV with intra-abdominal organ observed in inguinal canal | Unclear |
| Toki, 2003 | Ultrasound | 10.0 MHz annular array transducer | At rest and straining | (A) PPV with intra-abdominal organ observed in inguinal canal | Unclear |
| Uno, 1992 | Ultrasound | 3.75 MHz convex array transducer | Unclear | Unclear | Boys ≥ 7 mm |
| Zaidi, 2017 | Ultrasound | 7.5–11.0 MHz linear array transducer | Unclear | Inguinal hernia/PPV if maximum observed diameter of the inguinal canal at the internal ring ≥ 4.5 mm | PPV ≥ 4.5 mm |
PPV patent processus vaginalis, WLIR width of low echoic region of the internal ring
aWLIR of contralateral side as criteria for diagnosis of contralateral PPV or inguinal hernia
Fig. 2Methodological quality assessment of the included studies using the QUADAS-2 tool. a Risk of bias and applicability concerns summary about each domain are shown for each included study; b risk of bias and applicability concerns about each domain presented as percentages across included studies. Red circle with minus sign, high risk; yellow circle with question mark, unclear risk; green circle with plus sign, low risk
Diagnostic accuracy test results from studies that were excluded from the meta-analysis (n = 7)
| Author, year | Patients ( | TP | FP | FN | TN | Follow-up (months) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | US CPPV/MCIH (%) | Clinical CPPV/MCIH (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chen, 1998 | 203 | 62 | 3 | – | – | – | – | – | 95.4 | – | 32.0 | – |
| Hasanuzzaman, 2011 | 30 | 11 | 1 | – | – | – | – | – | 91.7 | – | 40.0 | – |
| Hata, 2004 | 348 | 74 | 4 | – | – | – | – | – | 94.9 | – | 22.4 | – |
| Kaneda, 2015a | 105 | 9 | 27 | 2 | 67 | 36 | 81.8 | 71.3 | 25 | 97.1 | 34.3 | 10.5 |
| Kazez, 2001a | 29 | 0 | 11 | 0 | 18 | 11 | – | 62 | – | 100 | 37.9 | 0 |
| Kervancioglu, 2000 | 121 | 10 | 0 | – | – | 6–12 | – | – | 100 | – | 8.3 | – |
| Toki, 2003 | 271 | – | – | 4 | – | 24 | – | – | – | – | – | – |
TP true positive, FP false positive, FN false negative, TN true negative, PPV positive predictive value, NPV negative predictive value, US ultrasound, CPPV contralateral patent processus vaginalis, MCIH metachronous contralateral inguinal hernia
aClinical findings during follow-up were used to calculate the amount of true positives (TP), false positives (FP), false negatives (FN) and true negatives (TN)
Diagnostic accuracy test results from complete cases included in the meta-analysis (n = 4). Complete cases: all patients underwent both the index test (preoperative ultrasonography) and reference test (surgical exploration), irrespective of the index test results. Clinical findings during follow-up (if reported) were used to calculate the amount of false negatives (FN) and true negatives (TN)
| Author, year | Patients | TP | FP | FN | TN | Sensitivity | Specificity | PPV | NPV | US CPPVa | OR CPPVb (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chou, 1996 | 179 | 49 | 11 | 0 | 119 | 100 | 91.5 | 81.7 | 100 | 33.5 | 27.4 |
| Kazez, 1998 | 46 | 23 | 2 | 1 | 20 | 95.8 | 90.9 | 92 | 95.2 | 54.3 | 52.2 |
| Lawrenz, 1994 | 23 | 14 | 4 | 4 | 1 | 77.8 | 20.0 | 77.8 | 20.0 | 78.3 | 78.3 |
| Shehata, 2013 | 246 | 75 | 20 | 7 | 144 | 91.7 | 87.7 | 75.9 | 96.2 | 38.6 | 33.3 |
TP true positive, FP false positive, FN false negative, TN true negative, PPV positive predictive value, NPV negative predictive value, US ultrasound, CPPV contralateral patent processus vaginalis
aAmount (%) of contralateral patent processus vaginalis as determined by ultrasonography
bAmount (%) of contralateral patent processus vaginalis detected intraoperatively
Fig. 3Pooled sensitivity and specificity forest plots including the 95% confidence intervals (CI) of a complete cases and b incomplete cases
Fig. 4Summary receiver operating characteristic curve of preoperative ultrasonography for detection of contralateral patent processus vaginalis in a complete cases and b incomplete cases. SROC summary receiver operating characteristic curve, AUC area under the curve
Diagnostic accuracy test results from incomplete cases included in the meta-analysis (n = 3). Incomplete cases: surgical exploration was only performed when the index test (preoperative ultrasonography) yielded positive test results. Clinical findings during follow-up (if reported) were used to calculate the amount of false negatives (FN) and true negatives (TN)
| Author, year | Patients ( | TP | FP | FN | TN | Follow-up (months) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | US CPPVa (%) | Clinical MCIHb (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Erez, 1996 | 200 | 38 | 2 | 0 | 160 | 36–48 | 100 | 98.8 | 95.0 | 100 | 20.0 | 19.0 |
| Uno, 1992 | 32 | 4 | 1 | 0 | 27 | ≥ 12 | 100 | 96.4 | 80 | 100 | 15.6 | 12.5 |
| Zaidi, 2017 | 287 | 39 | 6 | 13 | 229 | ≤ 24 | 75.0 | 97.4 | 86.7 | 94.6 | 15.7 | 18.1 |
TP true positive, FP false positive, FN false negative, TN true negative, PPV positive predictive value, NPV negative predictive value, US ultrasound, CPPV contralateral patent processus vaginalis, MCIH metachronous contralateral inguinal hernia
aAmount (%) of contralateral patent processus vaginalis as determined by ultrasonography
bAmount (%) of metachronous contralateral inguinal hernias that occurred during clinical follow-up